Cargando…
FRI094 Case Report: Treatment Of Sitosterolemia With Ezetimibe - 17 Years Of Follow-up
Disclosure: J.V. Coutinho: None. A.S. Costa: None. M.M. Issa: None. N.P. Paim: None. E.P. Quedas: None. V.S. Nunes: None. A.L. Jorge: None. E.R. Nakandakare: None. A.F. Carrilho: None. Background: Sitosterolemia is a rare autosomal recessive disease caused by inactivating mutations in the ABCG5 or A...
Autores principales: | Vieira Coutinho, Jean Gabriel, Santos Costa, Ana Carolina, Moura Issa, Milka Maria, Pereira Paim, Neiva, Quedas, Elisangela P S, Sutti Nunes, Valeria, Lima Jorge, Alexander Augusto, Regina Nakandakare, Edna, Faria Carrilho, Alexandre Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554984/ http://dx.doi.org/10.1210/jendso/bvad114.608 |
Ejemplares similares
-
FRI087 Tuberous Xanthomas And Thrombocytopenia In A Patient With A New Diagnosis Of Sitosterolemia
por: Grigoryan, Seda, et al.
Publicado: (2023) -
A case of sitosterolemia due to compound heterozygous mutations in
ABCG5: clinical features and treatment outcomes obtained
with colestimide and ezetimibe
por: Ono, Sahoko, et al.
Publicado: (2017) -
Sitosterolemia Exhibiting Severe Hypercholesterolemia with Tendon Xanthomas Due to Compound Heterozygous ABCG5 Gene Mutations Treated with Ezetimibe and Alirocumab
por: Tanaka, Hiroki, et al.
Publicado: (2020) -
Diagnosis and Management of Sitosterolemia 2021
por: Tada, Hayato, et al.
Publicado: (2021) -
Features of chinese patients with sitosterolemia
por: Zhou, Zhizi, et al.
Publicado: (2022)